Skip to Content

Genetics Hall of Fame

 


Guillermina Lozano, Ph.D.
Raycroft L, Wu HY, Lozano G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. (1990) Science  249 (4972) 1049-51

 


Richard R. Behringer, Ph.D.
Shawlot W, Behringer RR. (1995) Requirement for Lim1 in head-organizer function. Nature 374(6521):425-430 

 


Benoit DeCrombrugghe, M.D.
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29

News

Dr. Nicholas Navin wins notable AAAS Martin & Rose Wachtel Cancer Research Award


Nicholas Navin, Ph.D.
Assistant Professor

The American Association for the Advancement of Science (AAAS) Wachtel Award is an annual award that honors early career investigators performing outstanding work in cancer research. Winners receive a cash prize, deliver a public lecture on their research and have their award entry essay published in the journal Science Translational Medicine. Dr. Navin was selected for his research on single-cell DNA analysis. He will present his work at the National Institutes of Health on July 31, 2015.

Dr. Guillermina Lozano receives the 2015 Paul E. Darlington Award for Outstanding Mentoring


Gigi Lozano, Ph.D.
Chair & Professor

This award recognizes a current GSBS faculty member who has made an exceptional impact, as a mentor, on students and faculty.

Dr. Jill Schumacher receives the 2015 John P. McGovern Award for Outstanding Teaching


Jill Schumacher, Ph.D.
Associate Professor

This award recognizes faculty for outstanding excellence in teaching.

Dr. Guillermina Lozano elected to the Institute of Medicine (IOM) of the National Academies


Gigi Lozano, Ph.D.
Chair & Professor

Dr. Lozano is now one of nine MD Anderson faculty members in the IOM. She was recognized for her work on the p53 tumor suppressor pathway, specifically in regards to understanding the role of p53 mutants in tumorigenesis and the roles of Mdm2 and Mdm4 as inhibitors of p53.


© 2015 The University of Texas MD Anderson Cancer Center